Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development

American Journal of Pathology

Volumn 174, Issue 4, 2009, Pages 1160-1171

  Gattenlöhner, Stefan ^a   Stühmer, Thorsten ^a   Leich, Ellen ^a   Reinhard, Matthias ^a   Etschmann, Benjamin ^a   Völker, Hans Ulrich ^a   Rosenwald, Andreas ^a   Serfling, Edgar ^a   Bargou, Ralf Christian ^a   Ertl, Georg ^b   Einsele, Hermann ^a   Müller Hermelink, Hans Konrad ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Immunoglobe Antikoerpertechnik GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; NERVE CELL ADHESION MOLECULE; PHOSPHOTRANSFERASE; ANTIBODY; DIAGNOSTIC AGENT; ISOPROTEIN; TUMOR MARKER;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRECANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CANCER INVASION; DISEASE COURSE; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, CD56; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE PROGRESSION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 65349112434     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080647     Document Type: Article

References (86)

1. Brümmendorf T, Lemmon V: Immunoglobulin superfamily receptors: cis-interactions, intracellular adapters and alternative splicing regulate adhesion. Curr Opin Cell Biol 2001, 13:611-618
2. Walmod PS, Kolkova K, Berezin V, Bock E: Zippers make signals: NCAM-mediated molecular interactions and signal transduction. Neurochem Res 2004, 29:2015-2035
3. Walsh FS, Putt W, Dickson JG, Quinn CA, Cox RD, Webb M, Spurr N, Goodfellow PN: Human N-CAM gene: mapping to chromosome 11 by analysis of somatic cell hybrids with mouse and human cDNA probes. Brain Res 1986, 387:197-200
4. Nguyen C, Mattei MG, Mattei JF, Santoni MJ, Goridis C, Jordan BR: Localization of the human NCAM gene to band q23 of chromosome 11: the third gene coding for a cell interaction molecule mapped to the distal portion of the long arm of chromosome 11. J Cell Biol 1986, 102:711-715
5. Amoureux MC, Cunningham BA, Edelman GM, Crossin KL: N-CAM binding inhibits the proliferation of hippocampal progenitor cells and promotes their differentiation to a neuronal phenotype. J Neurosci 2000, 20:3631-3640
6. Cambon K, Venero C, Berezin V, Bock E, Sandi C: Post-training administration of a synthetic peptide ligand of the neural cell adhesion molecule, C3d, attenuates long-term expression of contextual fear conditioning. Neuroscience 2003, 122:183-191
7. Ditlevsen DK, Kohler LB, Pedersen MV, Risell M, Kolkova K, Meyer M, Berezin V, Bock E: The role of phosphatidylinositol 3-kinase in neural cell adhesion molecule-mediated neuronal differentiation and survival. J Neurochem 2003, 84:546-556
8. Kiryushko D, Kofoed T, Skladchikova G, Holm A, Berezin V, Bock E: A synthetic peptide ligand of neural cell adhesion molecule (NCAM), C3d, promotes neuritogenesis and synaptogenesis and modulates presynaptic function in primary cultures of rat hippocampal neurons. J Biol Chem 2003, 278:12325-12334
9. Prag S, Lepekhin EA, Kolkova K, Hartmann-Petersen R, Kawa A, Walmod PS, Belman V, Gallagher HC, Berezin V, Bock E, Pedersen N: NCAM regulates cell motility. J Cell Sci 2002, 115:283-292
10. Ronn LC, Berezin V, Bock E: The neural cell adhesion molecule in synaptic plasticity and ageing. Int J Dev Neurosci 2000, 18:193-199
11. Williams EJ, Furness J, Walsh FS, Doherty P: Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron 1994, 13:583-594
12. Paratcha G, Ledda F, Ibanez CF: The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 2003, 113:867-879
13. Cole GJ, Schubert D, Glaser L: Cell-substratum adhesion in chick neural retina depends upon protein-heparan sulfate interactions. J Cell Biol 1985, 100:1192-1199
14. Cole GJ, Glaser L: A heparin-binding domain from N-CAM is involved in neural cell-substratum adhesion. J Cell Biol 1986, 102:403-412
15. Cole GJ, Akeson R: Identification of a heparin binding domain of the neural cell adhesion molecule N-CAM using synthetic peptides. Neuron 1989, 2:1157-1165
16. Sariola H, Saarma M: Novel functions and signalling pathways for GDNF. J Cell Sci 2003, 116:3855-3862
17. Frei T, von Bohlen und Halbach F, Wille W, Schachner M: Different extracellular domains of the neural cell adhesion molecule (N-CAM) are involved in different functions. J Cell Biol 1992, 118:177-194
18. Burg MA, Halfter W, Cole GJ: Analysis of proteoglycan expression in developing chicken brain: characterization of a heparan sulfate proteoglycan that interacts with the neural cell adhesion molecule. J Neurosci Res 1995, 41:49-64
19. Grumet M, Rutishauser U, Edelman GM: Neural cell adhesion molecule is on embryonic muscle cells and mediates adhesion to nerve cells in vitro. Nature 1982, 295:693-695
20. Grumet M, Flaccus A, Margolis RU: Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules. J Cell Biol 1993, 120:815-824
21. Milev P, Meyer-Puttlitz B, Margolis RK, Margolis RU: Complex-type asparagine-linked oligosaccharides on phosphacan and proteintyrosine phosphatase-zeta/beta mediate their binding to neural cell adhesion molecules and tenascin. J Bio Chem 1995, 270:24650-24653
22. Storms SD, Kim AC, Tran BH, Cole GJ, Murray BA: NCAM-mediated adhesion of transfected cells to agrin. Cell Adhes Commun 1996, 3:497-509
23. Storms SD, Anvekar VM, Adams LD, Murray BA: Heterophilic NCAM- mediated cell adhesion to proteoglycans from chick embryonic brain membranes. Exp Cell Res 1996, 223:385-394
24. Rutishauser U, Grumet M, Edelman GM: Neural cell adhesion molecule mediates initial interactions between spinal cord neurons and muscle cells in culture. J Cell Biol 1983, 97:145-152
25. Edelman GM: Cell adhesion molecules in neural histogenesis. Annu Rev Physiol 1986, 48:417-430
26. Edelman GM, Jones FS: Gene regulation of cell adhesion: a key step in neural morphogenesis. Brain Res Brain Res Rev 1998, 26:337-352
27. Moretta A, Ciccone E, Tambussi G, Bottino C, Viale O, Pende D, Santoni A, Mingari MC: Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells. Int J Cancer Suppl 1989, 4:48-52
28. Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, Orengo A, Barbaresi M, Merli A, Ciccone E, Moretta L: Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990, 172: 1589-1598
29. Zeromski J, Szczepanski M, Mozer L: [Prevalence of CD56 /NCAM molecule in nervous system immune system and endocrine glands- accidental coincidence?]. Endokrynol Pol 2005, 56:78-82
30. Etzell JE, Keet C, McDonald W, Banerjee A: Medulloblastoma simulating acute myeloid leukemia: case report with a review of "myeloid antigen" expression in nonhematopoietic tissues and tumors. J Pedi- atr Hematol Oncol 2006, 28:703-710
31. Liang X, Graham DK: Natural killer cell neoplasms. Cancer 2008, 112:1425-1436
32. Liang X, Greffe B, Garrington T, Graham DK: Precursor natural killer cell leukemia. Pediatr Blood Cancer 2008, 50:876-878
33. Wick MR: Immunohistology of neuroendocrine and neuroectodermal tumors. Semin Diagn Pathol 2000, 17:194-203
34. Lechner O, Dietrich H, Oliveira dos Santos A, Wiegers GJ, Schwarz S, Harbutz M, Herold M, Wick G: Altered circadian rhythms of the stress hormone and melatonin response in lupus-prone MRL/MP-fas(Ipr) mice. J Autoimmun 2000, 14:325-333
35. Wick MR: Neuroendocrine neoplasia. Current concepts. Am J Clin Pathol 2000, 113:331-335
36. Wick MR, Ritter JH: Neuroendocrine neoplasia of the lung. Ann Thorac Surg 2000, 69:307-308
37. Strekalova H, Buhmann C, Kleene R, Eggers C, Saffell J, Hemperly J, Weiller C, Muller-Thomsen T, Schachner M: Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes. Neurobiol Aging 2006, 27:1-9
38. Kaiser U, Oldenburg M, Jaques G, Auerbach B, Havemann K: Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma. Ann Hematol 1996, 73:121-126
39. Kaiser U, Auerbach B, Oldenburg M: The neural cell adhesion molecule NCAM in multiple myeloma. Leuk Lymphoma 1996, 20:389-395
40. Ely SA, Knowles DM: Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation. Am J Pathol 2002, 160:1293-1299
41. Chang H, Samiee S, Yi QL: Prognostic relevance of CD56 expression in multiple myeloma: a study including 107 cases treated with high- dose melphalan-based chemotherapy and autologous stem cell transplant. Leuk Lymphoma 2006, 47:43-47
42. Kraj M, Sokolowska U, Kopec-Szlezak J, Poglod R, Kruk B, Wozniak J, Szpila T: Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma. Leuk Lymphoma 2008, 49:298-305
43. Raspadori D, Damiani D, Michieli M, Stocchi R, Gentili S, Gozzetti A, Masolini P, Michelutti A, Geromin A, Fanin R, Lauria F: CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome. Haematologica 2002, 87:1135-1140
44. Raspadori D, Damiani D, Lenoci M, Rondelli D, Testoni N, Nardi G, Sestigiani C, Mariotti C, Birtolo S, Tozzi M, Lauria F: CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 2001, 15:1161-1164
45. Ravandi F, Cortes J, Estrov Z, Thomas D, Giles FJ, Huh YO, Pierce S, O'Brien S, Faderl S, Kantarjian HM: CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leuk Res 2002, 26:643-649
46. Abbott JJ, Amirkhan RH, Hoang MP: Malignant melanoma with a rhabdoid phenotype: histologic, immunohistochemical, and ultra-structural study of a case and review of the literature. Arch Pathol Lab Med 2004, 128:686-688
47. Johnson JP: Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 1999,18:345-357
48. Pujol JL, Simony J, Demoly P, Charpentier R, Laurent JC, Daures JP, Lehmann M, Guyot V, Godard P, Michel FB: Neural cell adhesion molecule and prognosis of surgically resected lung cancer. Am Rev Respir Dis 1993, 148:1071-1075
49. Cho EY, Choi Y, Chae SW, Sohn JH, Ahn GH: Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms. Pathol Int 2006, 56:62-70
50. Choi YL, Xuan YH, Shin YK, Chae SW, Kook MC, Sung RH, Youn SJ, Choi JW, Kim SH: An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions. J Histochem Cytochem 2004, 52:591-601
51. Evans AJ, Humphrey PA, Belani J, van der Kwast TH, Srigley JR: Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer. Am J Surg Pathol 2006, 30:684-693
52. Zoltowska A, Stepinski J, Lewko B, Serkies K, Zamorska B, Roszkiewicz A, Izycka-Swieszewska E, Kruszewski WJ: Neural cell adhesion molecule in breast, colon and lung carcinomas. Arch Immunol Ther Exp (Warsz) 2001, 49:171-174
53. Daniel L, Bouvier C, Chetaille B, Gouvernet J, Luccioni A, Rossi D, Lechevallier E, Muracciole X, Coulange C, Figarella-Branger D: Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior. Hum Pathol 2003, 34:528-532
54. Brinkman BM: Splice variants as cancer biomarkers. Clin Biochem 2004, 37:584-594
55. Skotheim RI, Nees M: Alternative splicing in cancer: noise, functional, or systematic? Int J Biochem Cell Biol 2007, 39:1432-1449
56. Gattenloehner S, Chuvpilo S, Langebrake C, Reinhardt D, Muller-Hermelink HK, Serfling E, Vincent A, Marx A: Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression. Blood 2007, 110:2027-2033
57. Gattenlohner S, Waller C, Ertl G, Bultmann BD, Muller-Hermelink HK, Marx A: NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia. Am J Pathol 2003, 163:1081-1090
58. Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Muller-Hermelink HK, Ott G, Fend F, Rosenwald A: IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 2007, 31:1605-1614
59. Chatterjee M, Jain S, Stuhmer T, Andrulis M, Ungethum U, Kuban RJ, Lorentz H, Bommert K, Topp M, Kramer D, Muller-Hermelink HK, Einsele H, Greiner A, Bargou RC: STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival. Blood 2007, 109:720-728
60. Kobune M, Chiba H, Kato J, Kato K, Nakamura K, Kawano Y, Takada K, Takimoto R, Takayama T, Hamada H, Niitsu Y: Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism. Mol Cancer Ther 2007, 6:1774-1784
61. Nimmanapalli R, Gerbino E, Dalton WS, Gandhi V, Alsina M: HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma. Br J Haematol 2008, 142:551-561
62. Rendtlew Danielsen JM, Knudsen LM, Dahl IM, Lodahl M, Rasmussen T: Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma. Br J Haematol 2007, 138:756-760
63. Mock BA, Hartley J, Le Tissier P, Wax JS, Potter M: The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4. Blood 1997, 90:4092-4098
64. Adams H, Schmid P, Dirnhofer S, Tzankov A: Cytokeratin expression in hematological neoplasms: a tissue microarray study on 866 lym- phoma and leukemia cases. Pathol Res Pract 2008, 204:569-573
65. Xu D, Zheng C, Bergenbrant S, Holm G, Bjorkholm M, Yi Q, Gruber A: Telomerase activity in plasma cell dyscrasias. Br J Cancer 2001, 84:621-625
66. Benatti P, Basile V, Merico D, Fantoni LI, Tagliafico E, Imbriano C: A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response. Nucleic Acids Res 2008, 36:1415-1428
67. Ariazi EA, Gould MN: Identifying differential gene expression in monoterpene-treated mammary carcinomas using subtractive display. J Biol Chem 1996, 271:29286-29294
68. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H, Muller-Tidow C: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041
69. Perez DS, Hoage TR, Pritchett JR, Ducharme-Smith AL, Halling ML, Ganapathiraju SC, Streng PS, Smith DI: Long, abundantly expressed non-coding transcripts are altered in cancer. Hum Mol Genet 2008, 17:642-655
70. Kyle RA, Rajkumar SV: Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Br J Haematol 2007, 139:730-743
71. Rawstron AC, Orfao A, Beksac M, Bezdickova L, Brooimans RA, Bumbea H, Dalva K, Fuhler G, Gratama J, Hose D, Kovarova L, Lioznov M, Mateo G, Morilla R, Mylin AK, Omede P, Pellat-Deceunynck C, Perez Andres M, Petrucci M, Ruggeri M, Rymkiewicz G, Schmitz A, Schreder M, Seynaeve C, Spacek M, de Tute RM, Van Valckenborgh E, Weston-Bell N, Owen RG, San Miguel JF, Sonneveld P, Johnsen HE: Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haemato- logica 2008, 93:431-438
72. Kramer EM, Klein C, Koch T, Boytinck M, Trotter J: Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J Biol Chem 1999, 274:29042-29049
73. Pollerberg GE, Schachner M, Davoust J: Differentiation state-dependent surface mobilities of two forms of the neural cell adhesion molecule. Nature 1986, 324:462-465
74. Pollerberg GE, Burridge K, Krebs KE, Goodman SR, Schachner M: The 180-kD component of the neural cell adhesion molecule N-CAM is involved in cell-cell contacts and cytoskeleton-membrane interactions. Cell Tissue Res 1987, 250:227-236
75. Leshchyns'ka I, Sytnyk V, Morrow JS, Schachner M: Neural cell adhesion molecule (NCAM) association with PKCbeta2 via betaI spectrin is implicated in NCAM-mediated neurite outgrowth. J Cell Biol 2003, 161:625-639
76. Buttner B, Kannicht C, Reutter W, Horstkorte R: The neural cell adhesion molecule is associated with major components of the cy- toskeleton. Biochem Biophys Res Commun 2003, 310:967-971
77. Rodriguez-Mora OG, Lahair MM, Evans MJ, Kovacs CJ, Allison RR, Sibata CH, White KS, McCubrey JA, Franklin RA: Inhibition of the CaM-kinases augments cell death in response to oxygen radicals and oxygen radical inducing cancer therapies in MCF-7 human breast cancer cells. Cancer Biol Ther 2006, 5:1022-1030
78. Rodriguez-Mora OG, LaHair MM, McCubrey JA, Franklin RA: Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. Cancer Res 2005, 65:5408-5416
79. Rodriguez-Mora O, LaHair MM, Howe CJ, McCubrey JA, Franklin RA: Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy. Expert Opin Ther Targets 2005, 9:791-808
80. Dunphy CH, Nies MK, Gabriel DA: Correlation of plasma cell percentages by CD138 immunohistochemistry, cyclin D1 status, and CD56 expression with clinical parameters and overall survival in plasma cell myeloma. Appl Immunohistochem Mol Morphol 2007, 15:248-254
81. Perez-Andres M, Almeida J, Martin-Ayuso M, Moro MJ, Martin-Nunez G, Galende J, Borrego D, Rodriguez MJ, Ortega F, Hernandez J, Moreno I, Dominguez M, Mateo G, San Miguel JF, Orfao A: Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immu- nological bone marrow microenvironment. Leukemia 2005, 19:449-455
82. Kawase T, Hamazaki M, Ogura M, Kawase Y, Murayama T, Mori Y, Nagai H, Tateno M, Oyama T, Kamiya Y, Taji H, Kagami Y, Naoe T, Takahashi T, Morishima Y, Nakamura S: CD56/NCAM-positive Langer- hans cell sarcoma: a clinicopathologic study of 4 cases. Int J Hematol2005, 81:323-329
83. Barthels D, Vopper G, Boned A, Cremer H, Wille W: High degree of NCAM diversity generated by alternative RNA splicing in brain and muscle. Eur J Neurosci 1992, 4:327-337
84. Dickson G, Gower HJ, Barton CH, Prentice HM, Elsom VL, Moore SE, Cox RD, Quinn C, Putt W, Walsh FS: Human muscle neural cell adhesion molecule (N-CAM): identification of a muscle-specific sequence in the extracellular domain. Cell 1987, 50:1119-1130
85. Reyes AA, Small SJ, Akeson R: At least 27 alternatively spliced forms of the neural cell adhesion molecule mRNA are expressed during rat heart development. Mol Cell Biol 1991, 11:1654-1661
86. Santoni MJ, Barthels D, Vopper G, Boned A, Goridis C, Wille W: Differential exon usage involving an unusual splicing mechanism generates at least eight types of NCAM cDNA in mouse brain. EMBO J 1989, 8:385-392